Lyell Immunopharma, Inc.
USD13.32
-0.57 (-4.10%)
CEO
Lynn Seely
IPO Date
2021-06-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$13.81
Prev. Close
$13.89
Day Low
$13.06
Day High
$13.90
52W Low
$9.28
52W High
$45.00
Market Cap
$0.31B
Volume
0.17M
| Disposed |
| 76,000 |
| $0.00 |
| 18 Jun 2026 | Innovative Cellular Therapeutics Holdings Ltd | 10 percent owner | Disposed | 0 | $0.00 |
| 18 Jun 2026 | Innovative Cellular Therapeutics Holdings Ltd | 10 percent owner | J-Other | Disposed | 66,500 | $0.00 |
| 15 Jun 2026 | Seely Lynn | director, officer: President and CEO | S-Sale | Disposed | 388 | $18.91 |
| 15 Jun 2026 | Lee Gary K. | Chief Scientific Officer | S-Sale | Disposed | 130 | $18.92 |
| 15 Jun 2026 | Hill Stephen J. | Chief Operating Officer | S-Sale | Disposed | 89 | $18.92 |
| 15 Jun 2026 | Bulis Veronica Sanchez | VP, Corporate Controller | S-Sale | Disposed | 217 | $18.91 |
| 12 Jun 2026 | RIEFLIN WILLIAM JL | director | A-Award | Acquired | 9,250 | $13.22 |
| 12 Jun 2026 | Ramachandra Sumant | director | A-Award | Acquired | 9,250 | $13.22 |